| Title | Vaccine Adjuvants Market Worth $1.6 Billion by 2027 - Exclusive Report by MarketsandMarkets™ |
|---|
| URL | http://www.sbwire.com/press-releases/vaccine-adjuvants-market-worth-16-billion-by-2027-exclusive-report-by-marketsandmarketstm-1363585.htm |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Vaccine Adjuvants Market |
|---|
| Meta Description | In October 2021, Dynavax Technologies (US) entered into a fully funded collaboration with the US Department of Defense to conduct a Phase 2 clinical trial for a plague vaccine adjuvanted with CpG 1018 |
|---|
| Owner | Vaccine Adjuvants Market |
|---|
| Description |
|---|
| In October 2021, Dynavax Technologies (US) entered into a fully funded collaboration with the US Department of Defense to conduct a Phase 2 clinical trial for a plague vaccine adjuvanted with CpG 1018 |
